These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer. Luo X, Wu Y, Ji M, Zhang S. Clin Lab; 2019 May 01; 65(5):. PubMed ID: 31115212 [Abstract] [Full Text] [Related]
5. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Imaoka H, Toiyama Y, Fujikawa H, Hiro J, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Mori T, Kato T, Toden S, Goel A, Kusunoki M. Ann Oncol; 2016 Oct 01; 27(10):1879-86. PubMed ID: 27502702 [Abstract] [Full Text] [Related]
9. A plasma microRNA panel for detection of colorectal adenomas: a step toward more precise screening for colorectal cancer. Kanaan Z, Roberts H, Eichenberger MR, Billeter A, Ocheretner G, Pan J, Rai SN, Jorden J, Williford A, Galandiuk S. Ann Surg; 2013 Sep 01; 258(3):400-8. PubMed ID: 24022433 [Abstract] [Full Text] [Related]
14. Hypoxia Induces Drug Resistance in Colorectal Cancer through the HIF-1α/miR-338-5p/IL-6 Feedback Loop. Xu K, Zhan Y, Yuan Z, Qiu Y, Wang H, Fan G, Wang J, Li W, Cao Y, Shen X, Zhang J, Liang X, Yin P. Mol Ther; 2019 Oct 02; 27(10):1810-1824. PubMed ID: 31208913 [Abstract] [Full Text] [Related]
16. Influence of miR-199a on rats with non-small cell lung cancer via regulating the HIF-1α/VEGF signaling pathway. Wang LM, Zhang LL, Wang LW, Zhu L, Ma XX. Eur Rev Med Pharmacol Sci; 2019 Dec 02; 23(23):10363-10369. PubMed ID: 31841190 [Abstract] [Full Text] [Related]